ConductScience.org, home

Trial · NCT07907250

F-18 Sodium Fluoride PET/CT-Guided Pain Palliation in Chronic Plantar Fasciitis: A Comparative Study of ¹⁷⁷Lutetium-Corticosteroid-Local Anaesthetic Injection vs Corticosteroid-Local Anaesthetic Injection

NCT07907250, Not applicable, Recruiting, Post Graduate Institute of Medical Education and Research, Chandigarh

3 sourcestrials-2026-11-12-0.5.0

Download JSON
Cite this record

ConductScience Library. F-18 Sodium Fluoride PET/CT-Guided Pain Palliation in Chronic Plantar Fasciitis: A Comparative Study of ¹⁷⁷Lutetium-Corticosteroid-Local Anaesthetic Injection vs Corticosteroid-Local Anaesthetic Injection. Trials, record NCT07907250. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07907250

On this page

Trial

As registered on ClinicalTrials.gov, in the graph's capture of the registry.

Title
F-18 Sodium Fluoride PET/CT-Guided Pain Palliation in Chronic Plantar Fasciitis: A Comparative Study of ¹⁷⁷Lutetium-Corticosteroid-Local Anaesthetic Injection vs Corticosteroid-Local Anaesthetic Injection
NCT number
NCT07907250
Status
Recruiting
Phases
Not applicable
Enrollment
40 participants, estimated
Lead sponsor
Post Graduate Institute of Medical Education and Research, Chandigarh
Conditions
Plantar Fascitis, Chronic Heel Pain
Interventions
Patients receiving F-18 NaF PET/CT-guided Lutetium-177 - corticosteroid - local anesthetic, Patients receiving F-18 sodium fluoride PET/CT-guided corticosteroid - local anaesthetic
First posted
2026-10-30
Last updated
2026-10-30

Source ClinicalTrials.gov

Registered outcomes4

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

ListOutcomeTime frameDescription
PrimaryChange in Manchester-Oxford Foot Questionnaire (MOXFQ score) and 12-Item Short Form Health Survey (SF-12 questionnaire)3 months from baselineChange in Manchester-Oxford Foot Questionnaire (MOXFQ score) and 12-Item Short Form Health Survey (SF-12 questionnaire) from baseline to 3 months.
SecondaryChange in VAS score3 months from baselineChange in the Visual analogue scale (0-10)
SecondaryChange in SUVmax3 monthsChange in the osteoblastic activity (measured by SUVmax) at the plantar fascia insertion point
SecondaryAdverse events following Lutetium 177 administration3 and 6 monthsAny adverse events because of the administartion of lutetium 177 will be assessed

Outcomes0

Each outcome the trial posted results for, in ClinicalTrials.gov's words.

None in this release.

Results by group0

Each measurement the trial posted, group by group, in the words and numbers it posted.

None in this release.

Participant flow0

How many started, completed or left each group, period by period.

None in this release.

Adverse events0

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

None in this release.

Adverse event totals0

The totals the trial posted for each group.

None in this release.

Papers0

The papers the trial lists on ClinicalTrials.gov.

None in this release.

Grants0

The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.

None in this release.

Trial comparisons0

Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.

None in this release.

Tests0

The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.

None in this release.

Data dates

The day each source was copied for this release.

ClinicalTrials.gov
2026-11-12
ClinicalTrials.gov
Results, from AACT
2026-03-23
AACT
NIH grant links
2026-11-13
NIH RePORTER

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this trial from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/trials/v1/NCT07907250

GET https://conductscience.org/api/trials/v1/NCT07907250/registered